HSFY6P

Q-omics provides the consensus-scored HSFY6P profile across patient tissues and cancer cell-line models. HSFY6P expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in THCA. Additionally, HSFY6P RNA expression shows 1,200 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight THCA, and STAD as cancer lineages where HSFY6P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes HSFY6P survival associations across molecular data types. HSFY6P RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

HSFY6P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	THCA (90)	view →

This table ranks reproducible HSFY6P RNA expression–survival associations across cancer types. High HSFY6P expression shows unfavorable associations in THCA and STAD. The THCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify THCA as the clearest survival context for HSFY6P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.134	0.942	<.001	90	view →
STAD	DFS	Tertile	All	0.223	0.657	.049	18	view →

Pink = unfavorable, green = favorable. all 2 lineages →

HSFY6P-THCA (OS)

Explore this curve interactively →